Recombinant human LH
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant human LH, covering 2018-03-27 to 2018-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve [Phase 2]